Svalheim KG, Andresen NK, Bjerre C, Gilje B, Jakobsen EH, Falk RS, Naume B, Kaasa S, Kyte JA (2026)
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer
Breast, 86, 104704 (in press)
DOI 10.1016/j.breast.2026.104704, PubMed 41581361

Seland M, Rognli S, Skaali T, Blomhoff R, Tjønnfjord GE, Eriksen AMA, Solvang G, Thorsen L (2025)
Distress, problems and unmet rehabilitation needs after haematopoietic stem cell transplantation for haematologic malignancies: A cross-sectional study
Eur J Oncol Nurs, 80, 103083 (in press)
DOI 10.1016/j.ejon.2025.103083, PubMed 41576829

Zilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C et al. (2026)
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial
Eur Urol Oncol (in press)
DOI 10.1016/j.euo.2026.01.001, PubMed 41565552